Seminars in Oncology
Volume 34, Supplement 5 , Pages S21-S28, December 2007

Mycosis Fungoides: Pathophysiology and Emerging Therapies

  • Madeleine Duvic

      Affiliations

    • Department of Dermatology, University of Texas M.D. Anderson Cancer Center, Houston, TX.
    • Corresponding Author InformationAddress reprint requests to Madeleine Duvic, MD, Professor of Internal Medicine and Dermatology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd. #434, Houston, TX 77030
    • Dr Duvic has received research grant support from Merck, Ligand, Gloucester, Curagen, Biogen, BioCryst, Yaupon, Cyclacel, Celgene, Novartis, and Allos. She has received honoraria from Merck, Ligand, and Novartis.
    • ,
  • Francine M. Foss

      Affiliations

    • Yale Cancer Center, New Haven, CT.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(07)00225-4

doi:10.1053/j.seminoncol.2007.11.006

Seminars in Oncology
Volume 34, Supplement 5 , Pages S21-S28, December 2007

Article Tools

* Image Usage & Resolution